We’ve completed an OTC investment into @SAFESCAN_AI (SN76) – a Bittensor subnet using decentralised AI to improve cancer diagnostics, founded by Mateusz Woźniak and Wojciech Jurkowlaniec. A 1 percent improvement in diagnostic accuracy saves lives. SafeScan is proving that decentralised AI can deliver that improvement at scale. SafeScan runs a global model competition where: •⁠ ⁠Medical partners provide clinical data •⁠ ⁠Miners build diagnosis models •⁠ ⁠Validators score them every 24 hours •⁠ ⁠Only the top performers earn DSV has invested in SafeScan because their melanoma model is being tested inside real dermatology clinics and already beats state-of-the-art baselines. Every day dozens of scientists are competing to improve their model, and they’ve got strong dermatology and ML research partnerships in place. The market hasn’t priced in what these guys are building. We are proud to add SN76 to DSV’s partnership portfolio.

⚕️ Introducing C2S-Scale 27B, our new Gemma open model that can translate complex single-cell gene expression data into “cell sentences” that LLMs can understand.